Arihant Jayawant Kadapure

Arihant Jayawant Kadapure

Auto-generated profile, based on publicly available information

Arihant Jayawant Kadapure

Department of Biochemistry, Karnatak University Dharwad, Dharwad, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2024 in Food Hydrocolloids
Verified
Journal Article
Closed access
MGManjushree Nagaraj Gunaki
Manjushree Nagaraj Gunaki
SMSaraswati P. Masti
Saraswati P. Masti
ODOshin Jacintha D'SOuza
Oshin Jacintha D'SOuza
MEManjunath P. Eelager
Manjunath P. Eelager
LKLingaraj Kariyappa Kurabetta
Lingaraj Kariyappa Kurabetta
SKS.K. Praveen Kumar
S.K. Praveen Kumar

26 June 2025 in Periodontal and Implant Research
Verified
Journal Article
Closed access
PDF file
BGBasavaraj Neelappa Gonal
Basavaraj Neelappa Gonal
Nagarjuna Prakash DalbanjanNagarjuna Prakash Dalbanjan
Nagarjuna Prakash Dalbanjan
AKArihant Jayawant Kadapure
Arihant Jayawant Kadapure
MGMaruti J. Gurav
Maruti J. Gurav
VCVishwanath B. Chachadi
Vishwanath B. Chachadi
SASuresh Basavaraj Arakera
Suresh Basavaraj Arakera

9 September 2025 in Discover Chemistry
Verified
Journal Article
Open access
PDF file
Nagarjuna Prakash DalbanjanNagarjuna Prakash Dalbanjan
Nagarjuna Prakash Dalbanjan
LBLokesh Bheemayya
Lokesh Bheemayya
AKArihant Jayawant Kadapure
Arihant Jayawant Kadapure
BKB. K. Kiran
B. K. Kiran
RKRavindra R. Kamble
Ravindra R. Kamble
SKS. K. Praveen Kumar
S. K. Praveen Kumar
In this study, a series of previously synthesized 3-(4,5-diaryl-1H-imidazol-2-yl)quinoline-2-amine derivatives (compounds a-d) were evaluated for their antihyperglycemic, antioxidant, and anti-inflammatory activities through in vitro and in silico approaches. Compound b (with a methyl group) inhibited α-amylase (IC50 = 115.88 µg/mL), but not as strongly as the standard drug acarbose (IC50 = 91.26 µg/mL). Kinetic studies indicated that compound b follows a mixed competitive inhibition mechanism, differing from acarbose’s competitive inhibition. Normal mode analysis further confirmed the stable binding of compound b to α-amylase. Compound b improved glucose uptake (IC50 = 117.25 µg/mL), though not as effectively as the standard antidiabetic drug pioglitazone (IC50 = 97.61 µg/mL). Compound c (chloro-substituted) showed strong antioxidant activity in DPPH (IC50 = 46.16 µg/mL) and ABTS+ (IC50 = 47.57 µg/mL) assays, though less potent than ascorbic acid (IC50 ≈ 26 µg/mL). It also exhibited good anti-inflammatory activity (IC50 = 214.45 µg/mL), while diclofenac sodium showed superior inhibition (IC50 = 122.66 µg/mL). Molecular docking confirmed strong interactions with α-amylase and PPAR-γ, with compound b displaying the lowest binding energies (-10.0 and − 11.1 kcal/mol, respectively). ADMET predictions suggested that compounds a (unsubstituted) and b possess favorable pharmacokinetic properties, including high gastrointestinal absorption and compliance with Lipinski’s rule of five, while compound d (methyl and chlorine substituted) exhibited poor solubility and potential respiratory toxicity. Although the tested compounds demonstrated efficacy comparable to standard drugs, further structural modifications are necessary to optimize their potency and therapeutic performance. AbstractSection Graphical abstract

1 December 2025 in Animals and Zoonoses
Verified
Journal Article
Open access
BGBasavaraj Neelappa Gonal
Basavaraj Neelappa Gonal
Nagarjuna Prakash DalbanjanNagarjuna Prakash Dalbanjan
Nagarjuna Prakash Dalbanjan
AKArihant Jayawant Kadapure
Arihant Jayawant Kadapure
SKS.K. Praveen Kumar
S.K. Praveen Kumar
SASuresh Basavaraj Arakera
Suresh Basavaraj Arakera

2 July 2025 in Antonie van Leeuwenhoek
Verified
Journal Article
Closed access
PDF file
Nagarjuna Prakash DalbanjanNagarjuna Prakash Dalbanjan
Nagarjuna Prakash Dalbanjan
AKArihant Jayawant Kadapure
Arihant Jayawant Kadapure
SKS. K. Praveen Kumar
S. K. Praveen Kumar

15 July 2025 in Microbiology
Verified
Journal Article
Closed access
PDF file
Nagarjuna Prakash DalbanjanNagarjuna Prakash Dalbanjan
Nagarjuna Prakash Dalbanjan
AKA. J. Kadapure
A. J. Kadapure
SKS. K. Praveen Kumar
S. K. Praveen Kumar
Soil ecosystems consist of diverse microbial communities with great potential for ecological and biotechnological applications. These communities encounter various abiotic stresses, which activate the transient overexpression of heat shock proteins (HSPs). In the present study, a soil bacterium was isolated and identified (biochemical characterization and 16S rRNA gene sequencing) as Bacillus haynesii strain PSK.N4, and its growth parameters were optimized before exposure to heat, salt, pH, and antibiotic stress conditions. The studied abiotic and antibiotic stress was induced by subjecting the bacterium to sublethal growth conditions. Comparative protein expression under stress conditions was analyzed using SDS-PAGE, protein stabilization via protein aggregation assays, and survival (colony counts). Short-term (10 min) pretreatment with the stressors showed elevated overall tolerance of bacterium to lethal conditions, as evidenced by moderately enhanced total content of soluble intracellular protein, better protein stabilization, comparatively over-expressed stress response proteins, and relatively enhanced cell survival. These findings revealed that cells grown under optimal conditions were more susceptible to lethal environments than stressed cells, with their enhanced tolerance linked to the overexpression of twenty distinct stress response proteins of ~17–88 kDa. These insights offer the potential for developing strategies to improve microbial resilience for various applications, including bacterial bioprocessing, bioremediation, and infectious disease management.